as on November 27, 2025 at 2:29 am IST
Day's Low
Day's High
2.26%
Downside
4.51%
Upside
52 Week's Low
52 Week's High
15.04%
Downside
521.80%
Upside
Check Inmed Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$3.9M
EPS (TTM)
0Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-0.51
Industry PE ratio
0PEG Ratio
0EBITDA
-7.7M
Revenue (TTM)
4.8M
Profit Margin
-171.13%
Return On Equity TTM
-82.17%
Track how Inmed Pharmaceuticals Inc P/E has moved over time to understand its valuation trends.
Inmed Pharmaceuticals Inc in the last 5 years
Lowest (-151.89x)
December 31, 2020
Industry (0.00x)
November 27, 2025
Today (-0.51x)
November 27, 2025
Highest (-0.35x)
September 30, 2024
Today’s Price to Earnings Ratio: -0.51x
Compare market cap, revenue, PE, and other key metrics of Inmed Pharmaceuticals Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| $3.9M | -99.92% | -0.51 | -171.13% | ||
| BUY | $22.1B | NA | 18.52 | 40.65% | |
| BUY | $43.7B | NA | 22.18 | 13.81% | |
| BUY | $14.3B | 58.62% | 33.69 | 15.95% | |
| BUY | $56.7B | -20.92% | 20.69 | 28.21% |
The Inmed Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Inmed Pharmaceuticals Inc investment value today
Current value as on today
₹36,723
Returns
Returns from Inmed Pharmaceuticals Inc Stock
Dollar Returns*
₹5,792 (+5.79%)
Based on 8 analysts
0.00%
Buy
37.50%
Hold
62.50%
Sell
Based on 8 analysts, 62.5% of analysts recommend a 'SELL' rating for Inmed Pharmaceuticals Inc. Average target price of $20
Get share price movements and forecasts by analysts on Inmed Pharmaceuticals Inc.
What analysts predicted
93.35%UPSIDE
Target Price
$20
Current Price
$1.33
Analyzed by
8 Analysts
Target
$20.00
Inmed Pharmaceuticals Inc target price $20, a slight upside of 93.35% compared to current price of $1.33. According to 8 analysts rating.
Search interest for Inmed Pharmaceuticals Inc Stock has increased by 114% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:114% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Profit Spike
![]()
Netprofit is up for the last 2 quarters, -2.43M → -1.72M (in $), with an average increase of 41.1% per quarter
Price Rise
![]()
In the last 1 year, INM stock has moved up by 76.5%
Retail Holding Up
![]()
Retail Investor have increased holdings from 21.76% to 26.20% in Sep 2025 quarter
Against Peers
![]()
In the last 1 year, United Therapeutics Corporation has given 29.2% return, outperforming this stock by 98.5%
Against Peers
![]()
In the last 3 years, United Therapeutics Corporation has given 82.2% return, outperforming this stock by 179.9%
Price Dip
![]()
In the last 1 month, INM stock has moved down by -35.3%
FII Holding Down
![]()
Foreign Institutions have decreased holdings from 7.99% to 5.26% in Sep 2025 quarter
Promoter Holding Down
![]()
Promoters have decreased holdings from 70.26% to 68.54% in Sep 2025 quarter
Revenue Fall
![]()
Revenue is down for the last 2 quarters, 1.77M → 1.12M (in $), with an average decrease of 37.0% per quarter
| Organisation | Inmed Pharmaceuticals Inc |
| Headquarters | 885 West Georgia Street, Vancouver, BC, Canada, V6C 3E8 |
| Industry | Health Technology |
| CEO | Mr. Eric A. Adams B.S. Chem., M.I.B. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Colin Clancy | Senior Director of Investor Relations |
Mr. Jerry P. Griffin | Vice President of Sales & Marketing |
Dr. Shane A. Johnson Ph.D. | Senior VP & GM of BayMedica |
Mr. Eric A. Adams B.S. Chem., M.I.B. | President, CEO & Director |
Ms. N. Netta Jagpal | CFO & Corporate Secretary |
Mr. Michael Woudenberg P.Eng. | Chief Operating Officer |
Dr. Eric Chih-Hsien Hsu Ph.D. | Senior Vice President of Preclinical Research & Development |
Dr. Sazzad Hossain M.Sc., Ph.D. | Co-Founder |
Inmed Pharmaceuticals Inc share price today is $1.33 as on at the close of the market. Inmed Pharmaceuticals Inc share today touched a day high of $1.39 and a low of $1.3.
Inmed Pharmaceuticals Inc share touched a 52 week high of $8.27 on and a 52 week low of $1.13 on . Inmed Pharmaceuticals Inc stock price today i.e. is closed at $1.33,which is 83.92% down from its 52 week high and 17.70% up from its 52 week low.
Inmed Pharmaceuticals Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Inmed Pharmaceuticals Inc (INM) shares with as little as ₹89.31 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹893.10 in Inmed Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Inmed Pharmaceuticals Inc share’s latest price of $1.33 as on November 27, 2025 at 2:29 am IST, you will get 7.5188 shares of Inmed Pharmaceuticals Inc. Learn more about
fractional shares .
Inmed Pharmaceuticals Inc stock has given -99.92% share price returns and 20.58% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?